Out of Stock

tavist 20mg tab

Manufactured By: MACTER PHARMA

This medicine is used as an adjunct to diet in hypercholesterolemia (high cholesterol), heterozygous (genetic disorder characterized with markedly increased LDL and cholesterol )and homozygous familial hypercholesterolemia (a condition in which it is difficult to remove bad cholesterol from body), mixed hyperlipidemia (genetic disorder characterized with high lipids (fats), cholesterol and free fatty acids in blood).

Tavist 20mg tablet

Tavist 20mg tablet is composed of atorvastatin calcium trihydrate (20mg)
Atorvastatin is a medicine that lowers the cholesterol.
It works by inhibiting the activity of an enzyme in the body that is involved in the formation of cholesterol. As a result, it aids in the reduction of levels of blood cholesterol. It also lowers the risk of cardiovascular disease.

Atorvastatin should be taken either with food or without food as advised by your doctor.
Take atorvastatin precisely as directed by your doctor.
The dosage is determined by your health condition, age as well as your reaction to treatment.
Swallow the tablet with water.
Do not crush, chew or break the tablet.
Do not discontinue taking Atorvastatin without first consulting your doctor.

This medicine is contraindicated in pregnant females. Consult your doctor before using this medicine.
Atorvastatin is not recommended for use by lactating females since it can have adverse effects on a nursing baby. Lactating females should consult their doctor before using atorvastatin.
Drive vehicles with caution.
People with liver diseases should consult their doctors before using atorvastatin.
People with kidney diseases should consult their doctors before using atorvastatin.
Avoid drinking alcohol while taking atorvastatin because it raises the risk of liver disease.

Elderly patients and patients with a history of alcohol abuse or liver disease, renal (kidney) impairment, hypothyroidism (low thyroid levels in blood), history of muscle toxicity or muscle disorders are sensitive to the drug. Liver function tests should be performed before and during the therapy.
Advice patients to report unusual muscle weakness or pain, maintain creatinine kinase levels, withdraw if liver > 5 x ULN.
There may be a risk of interstitial lung disease (inflammation and scarring of tissue that surrounds lung’s air sacs, blood vessels and airways) advice patients to report symptoms including dyspnea (difficulty in breathing), non-productive cough, fatigue (weakness), weight loss, fever.
Risk of new onset of diabetes risk factors include hypertension (high blood pressure), raised triglycerides, BMI and fasting glucose at baseline. There is risk of stroke and transient ischemic attack (a stroke that lasts for a few minutes in which blood supply to the part of brain is briefly stopped).